Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2009

Open Access 01-12-2009 | Review

Vasodilator factors in the systemic and local adaptations to pregnancy

Authors: Gloria Valdes, Peter Kaufmann, Jenny Corthorn, Rafaela Erices, K Bridget Brosnihan, JaNae Joyner-Grantham

Published in: Reproductive Biology and Endocrinology | Issue 1/2009

Login to get access

Abstract

We postulate that an orchestrated network composed of various vasodilatory systems participates in the systemic and local hemodynamic adaptations in pregnancy. The temporal patterns of increase in the circulating and urinary levels of five vasodilator factors/systems, prostacyclin, nitric oxide, kallikrein, angiotensin-(1–7) and VEGF, in normal pregnant women and animals, as well as the changes observed in preeclamptic pregnancies support their functional role in maintaining normotension by opposing the vasoconstrictor systems. In addition, the expression of these vasodilators in the different trophoblastic subtypes in various species supports their role in the transformation of the uterine arteries. Moreover, their expression in the fetal endothelium and in the syncytiotrophoblast in humans, rats and guinea-pigs, favour their participation in maintaining the uteroplacental circulation. The findings that sustain the functional associations of the various vasodilators, and their participation by endocrine, paracrine and autocrine regulation of the systemic and local vasoactive changes of pregnancy are abundant and compelling. However, further elucidation of the role of the various players is hampered by methodological problems. Among these difficulties is the complexity of the interactions between the different factors, the likelihood that experimental alterations induced in one system may be compensated by the other players of the network, and the possibility that data obtained by manipulating single factors in vitro or in animal studies may be difficult to translate to the human. In addition, the impossibility of sampling the uteroplacental interface along normal pregnancy precludes obtaining longitudinal profiles of the various players. Nevertheless, the possibility of improving maternal blood pressure regulation, trophoblast invasion and uteroplacental flow by enhancing vasodilation (e.g. L-arginine, NO donors, VEGF transfection) deserves unravelling the intricate association of vasoactive factors and the systemic and local adaptations to pregnancy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kaufmann P, Black S, Huppertz B: Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003, 69: 1-7.PubMedCrossRef Kaufmann P, Black S, Huppertz B: Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003, 69: 1-7.PubMedCrossRef
2.
go back to reference Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, Fisher SJ: Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest. 2004, 114: 744-754.PubMedCentralPubMedCrossRef Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, Fisher SJ: Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest. 2004, 114: 744-754.PubMedCentralPubMedCrossRef
3.
go back to reference Kaufmann P, Mayhew TM, Charnock-Jones DS: Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta. 2004, 25: 114-126.PubMedCrossRef Kaufmann P, Mayhew TM, Charnock-Jones DS: Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta. 2004, 25: 114-126.PubMedCrossRef
5.
go back to reference Hytten F: Blood volume changes in normal pregnancy. Clin Haematol. 1985, 14: 601-612.PubMed Hytten F: Blood volume changes in normal pregnancy. Clin Haematol. 1985, 14: 601-612.PubMed
6.
go back to reference Salas SP, Rosso P, Espinoza R, Robert JA, Valdés G, Donoso E: Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol. 1993, 81: 1029-1033.PubMed Salas SP, Rosso P, Espinoza R, Robert JA, Valdés G, Donoso E: Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol. 1993, 81: 1029-1033.PubMed
7.
go back to reference Wilson M, Morganti AA, Zervoudakis I, Letcher RL, Romney BM, Von Oeyon P, Papera S, Sealey JE, Laragh JH: Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med. 1980, 68: 97-104.PubMedCrossRef Wilson M, Morganti AA, Zervoudakis I, Letcher RL, Romney BM, Von Oeyon P, Papera S, Sealey JE, Laragh JH: Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med. 1980, 68: 97-104.PubMedCrossRef
8.
go back to reference Sala C, Campise M, Ambroso G, Motta T, Zanchetti A, Morganti A: Atrial natriuretic peptide and hemodynamic changes during normal human pregnancy. Hypertension. 1995, 25: 631-636.PubMedCrossRef Sala C, Campise M, Ambroso G, Motta T, Zanchetti A, Morganti A: Atrial natriuretic peptide and hemodynamic changes during normal human pregnancy. Hypertension. 1995, 25: 631-636.PubMedCrossRef
9.
go back to reference Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC: A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973, 52: 2682-2689.PubMedCentralPubMedCrossRef Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC: A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973, 52: 2682-2689.PubMedCentralPubMedCrossRef
10.
go back to reference Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Putte Van De LB, Lipsky PE: Cyclooxygenase in biology and disease. Faseb J. 1998, 12: 1063-1073.PubMed Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Putte Van De LB, Lipsky PE: Cyclooxygenase in biology and disease. Faseb J. 1998, 12: 1063-1073.PubMed
11.
go back to reference Gryglewski RJ: Prostacyclin among prostanoids. Pharmacol Rep. 2008, 60: 3-11.PubMed Gryglewski RJ: Prostacyclin among prostanoids. Pharmacol Rep. 2008, 60: 3-11.PubMed
13.
go back to reference Laszlo F, Whittle BJ, Moncada S: Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia. Br J Pharmacol. 1994, 113 (4): 1131-1136.PubMedCentralPubMedCrossRef Laszlo F, Whittle BJ, Moncada S: Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia. Br J Pharmacol. 1994, 113 (4): 1131-1136.PubMedCentralPubMedCrossRef
14.
go back to reference Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, Moncada S: Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J. 1996, 314 (Pt 3): 877-880.PubMedCentralPubMedCrossRef Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, Moncada S: Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J. 1996, 314 (Pt 3): 877-880.PubMedCentralPubMedCrossRef
15.
go back to reference Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A: The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 2005, 99: 6-38.PubMedCrossRef Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A: The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 2005, 99: 6-38.PubMedCrossRef
16.
go back to reference Brosnihan KB, Li P, Tallant EA, Ferrario CM: Angiotensin-(1–7): a novel vasodilator of the coronary circulation. Biol Res. 1998, 31: 227-234.PubMed Brosnihan KB, Li P, Tallant EA, Ferrario CM: Angiotensin-(1–7): a novel vasodilator of the coronary circulation. Biol Res. 1998, 31: 227-234.PubMed
17.
18.
go back to reference Brosnihan KB, Li P, Ferrario CM: Angiotensin-(1–7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996, 27: 523-528.PubMedCrossRef Brosnihan KB, Li P, Ferrario CM: Angiotensin-(1–7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996, 27: 523-528.PubMedCrossRef
19.
go back to reference Carvalho MB, Duarte FV, Faria-Silva R, Fauler B, da Mata Machado LT, de Paula RD, Campagnole-Santos MJ, Santos RA: Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1–7) nonpeptide mimic AVE 0991 in normotensive rats. Hypertension. 2007, 50: 762-767.PubMedCrossRef Carvalho MB, Duarte FV, Faria-Silva R, Fauler B, da Mata Machado LT, de Paula RD, Campagnole-Santos MJ, Santos RA: Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1–7) nonpeptide mimic AVE 0991 in normotensive rats. Hypertension. 2007, 50: 762-767.PubMedCrossRef
20.
go back to reference Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM: Angiotensin-(1–7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 2007, 49: 185-192.PubMedCrossRef Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM: Angiotensin-(1–7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 2007, 49: 185-192.PubMedCrossRef
21.
go back to reference Tallant EA, Clark MA: Molecular mechanisms of inhibition of vascular growth by angiotensin-(1–7). Hypertension. 2003, 42: 574-579.PubMedCrossRef Tallant EA, Clark MA: Molecular mechanisms of inhibition of vascular growth by angiotensin-(1–7). Hypertension. 2003, 42: 574-579.PubMedCrossRef
22.
go back to reference Li P, Chappell MC, Ferrario CM, Brosnihan KB: Angiotensin-(1–7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997, 29: 394-400.PubMedCrossRef Li P, Chappell MC, Ferrario CM, Brosnihan KB: Angiotensin-(1–7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997, 29: 394-400.PubMedCrossRef
23.
go back to reference Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T: Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999, 104: 925-935.PubMedCentralPubMedCrossRef Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T: Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999, 104: 925-935.PubMedCentralPubMedCrossRef
24.
go back to reference Widdop RE, Matrougui K, Levy BI, Henrion D: AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension. 2002, 40: 516-520.PubMedCrossRef Widdop RE, Matrougui K, Levy BI, Henrion D: AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension. 2002, 40: 516-520.PubMedCrossRef
25.
go back to reference Yayama K, Hiyoshi H, Imazu D, Okamoto H: Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor. Hypertension. 2006, 48: 958-964.PubMedCrossRef Yayama K, Hiyoshi H, Imazu D, Okamoto H: Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor. Hypertension. 2006, 48: 958-964.PubMedCrossRef
26.
go back to reference Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L: VEGF receptor signalling – in control of vascular function. Nat Rev Mol Cell Biol. 2006, 7: 359-371.PubMedCrossRef Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L: VEGF receptor signalling – in control of vascular function. Nat Rev Mol Cell Biol. 2006, 7: 359-371.PubMedCrossRef
27.
go back to reference Nagy JA, Dvorak AM, Dvorak HF: VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med. 2003, 13 (5): 169-175.PubMedCrossRef Nagy JA, Dvorak AM, Dvorak HF: VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med. 2003, 13 (5): 169-175.PubMedCrossRef
28.
go back to reference Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD: Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2003, 110 (Suppl 1): S10-18.PubMedCrossRef Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD: Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2003, 110 (Suppl 1): S10-18.PubMedCrossRef
29.
go back to reference Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995, 146: 1029-1039.PubMedCentralPubMed Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995, 146: 1029-1039.PubMedCentralPubMed
30.
go back to reference Brownbill PMT, Soydemir DF, Sibley CP: Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia. Placenta. 2008, 29: 950-955.PubMedCrossRef Brownbill PMT, Soydemir DF, Sibley CP: Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia. Placenta. 2008, 29: 950-955.PubMedCrossRef
31.
go back to reference Wheeler-Jones C, Abu-Ghazaleh R, Cospedal R, Houliston RA, Martin J, Zachary I: Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett. 1997, 420: 28-32.PubMedCrossRef Wheeler-Jones C, Abu-Ghazaleh R, Cospedal R, Houliston RA, Martin J, Zachary I: Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett. 1997, 420: 28-32.PubMedCrossRef
32.
go back to reference Tammela T, Enholm B, Alitalo K, Paavonen K: The biology of vascular endothelial growth factors. Cardiovasc Res. 2005, 65: 550-563.PubMedCrossRef Tammela T, Enholm B, Alitalo K, Paavonen K: The biology of vascular endothelial growth factors. Cardiovasc Res. 2005, 65: 550-563.PubMedCrossRef
33.
go back to reference Terragno A, McGiff JC, Smigel M, A T: Patterns of prostaglandin production in the bovine and fetal vasculature. Prostaglandins. 1978, 16: 847-855.CrossRef Terragno A, McGiff JC, Smigel M, A T: Patterns of prostaglandin production in the bovine and fetal vasculature. Prostaglandins. 1978, 16: 847-855.CrossRef
34.
go back to reference Myatt L, Elder MG: Inhibition of platelet aggregation by a placental substance with prostacyclin-like activity. Nature. 1977, 268: 159-160.CrossRef Myatt L, Elder MG: Inhibition of platelet aggregation by a placental substance with prostacyclin-like activity. Nature. 1977, 268: 159-160.CrossRef
35.
go back to reference Bolton PJ, Jogee M, Myatt L, Elder MG: Maternal plasma 6-oxo-prostaglandin F1 alpha throughout pregnancy: a longitudinal study. Br J Obstet Gynecol. 1981, 80: 1101-1103.CrossRef Bolton PJ, Jogee M, Myatt L, Elder MG: Maternal plasma 6-oxo-prostaglandin F1 alpha throughout pregnancy: a longitudinal study. Br J Obstet Gynecol. 1981, 80: 1101-1103.CrossRef
36.
go back to reference Bussolino F, Benedetto C, Massobrio M, Camussi G: Maternal vascular prostacyclin activity in pre-eclampsia. Lancet. 1980, 2 (8196): 702-PubMedCrossRef Bussolino F, Benedetto C, Massobrio M, Camussi G: Maternal vascular prostacyclin activity in pre-eclampsia. Lancet. 1980, 2 (8196): 702-PubMedCrossRef
37.
go back to reference Ylikorkala O, Pekonen F, Viinikka L: Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. J Clin Endocrinol Metab. 1986, 63: 1307-1312.PubMedCrossRef Ylikorkala O, Pekonen F, Viinikka L: Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. J Clin Endocrinol Metab. 1986, 63: 1307-1312.PubMedCrossRef
38.
go back to reference Wang YP, Walsh SW, Guo JD, Zhang JY: The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol. 1991, 165: 1695-1700.PubMedCrossRef Wang YP, Walsh SW, Guo JD, Zhang JY: The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol. 1991, 165: 1695-1700.PubMedCrossRef
39.
go back to reference Mills JL, DerSimonian R, Raymond E, Morrow JD, Roberts LJ, Clemens JD, Hauth JC, Catalano P, Sibai B, Curet LB, Levine RJ: Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. Jama. 1999, 282: 356-362.PubMedCrossRef Mills JL, DerSimonian R, Raymond E, Morrow JD, Roberts LJ, Clemens JD, Hauth JC, Catalano P, Sibai B, Curet LB, Levine RJ: Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. Jama. 1999, 282: 356-362.PubMedCrossRef
40.
go back to reference CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet. 1994, 343: 619-629. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet. 1994, 343: 619-629.
41.
go back to reference Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD: Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J. 1993, 7: 566-571.PubMed Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD: Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J. 1993, 7: 566-571.PubMed
42.
go back to reference Conrad KP, Vernier KA: Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol. 1989, 257: R847-853.PubMed Conrad KP, Vernier KA: Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol. 1989, 257: R847-853.PubMed
43.
go back to reference Molnar M, Suto T, Toth T, Hertelendy F: Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 1994, 170: 1458-1466.PubMedCrossRef Molnar M, Suto T, Toth T, Hertelendy F: Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 1994, 170: 1458-1466.PubMedCrossRef
44.
go back to reference Yallampalli C, Garfield RE: Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol. 1993, 169: 1316-1320.PubMedCrossRef Yallampalli C, Garfield RE: Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol. 1993, 169: 1316-1320.PubMedCrossRef
45.
go back to reference Conrad KP, Kerchner LJ, Mosher MD: Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol. 1999, 277: F48-57.PubMed Conrad KP, Kerchner LJ, Mosher MD: Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol. 1999, 277: F48-57.PubMed
46.
go back to reference Davidge ST, Stranko CP, Roberts JM: Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol. 1996, 174: 1008-1013.PubMedCrossRef Davidge ST, Stranko CP, Roberts JM: Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol. 1996, 174: 1008-1013.PubMedCrossRef
47.
go back to reference Schiessl B, Strasburger C, Bidlingmaier M, Mylonas I, Jeschke U, Kainer F, Friese K: Plasma- and urine concentrations of nitrite/nitrate and cyclic guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet. 2006, 274: 150-154.PubMedCrossRef Schiessl B, Strasburger C, Bidlingmaier M, Mylonas I, Jeschke U, Kainer F, Friese K: Plasma- and urine concentrations of nitrite/nitrate and cyclic guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet. 2006, 274: 150-154.PubMedCrossRef
48.
go back to reference Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH: Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet. 2003, 361: 1511-1517.PubMedCrossRef Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH: Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet. 2003, 361: 1511-1517.PubMedCrossRef
49.
go back to reference Salas SP, Roblero JS, Croxatto HR, Valdés G: Urinary kallikrein activity during rat pregnancy. Arch Biol Med Exp. 1987, 20: 305-309.PubMed Salas SP, Roblero JS, Croxatto HR, Valdés G: Urinary kallikrein activity during rat pregnancy. Arch Biol Med Exp. 1987, 20: 305-309.PubMed
50.
go back to reference Valdés G, Corthorn J, Oyarzún E, Berríos C, Foradori A, Germain AM, Villarroel L: Urinary kallikrein excretion in the human menstrual cycle, normal pregnancy and lactation. Prenat Neonat Med. 1998, 3: 474-481. Valdés G, Corthorn J, Oyarzún E, Berríos C, Foradori A, Germain AM, Villarroel L: Urinary kallikrein excretion in the human menstrual cycle, normal pregnancy and lactation. Prenat Neonat Med. 1998, 3: 474-481.
51.
go back to reference Elebute OA, Mills IH: Urinary kallikrein in normal and hypertensive pregnancies. Perspect Nephrol Hypertens. 1976, 5: 329-338.PubMed Elebute OA, Mills IH: Urinary kallikrein in normal and hypertensive pregnancies. Perspect Nephrol Hypertens. 1976, 5: 329-338.PubMed
52.
go back to reference Karlberg BERG, Wichman K: Changes in the renin-angiotensin-aldosterone and kallikrein-kinin systems during normal and hypertensive pregnancy. Acta Obstet Gynecol Scand. 1984, 118: 17-24.CrossRef Karlberg BERG, Wichman K: Changes in the renin-angiotensin-aldosterone and kallikrein-kinin systems during normal and hypertensive pregnancy. Acta Obstet Gynecol Scand. 1984, 118: 17-24.CrossRef
53.
go back to reference Kyle PM, Campbell S, Buckley D, Kissane J, de Swiet M, Albano J, Millar JG, Redman CW: A comparison of the inactive urinary kallikrein:creatinine ratio and the angiotensin sensitivity test for the prediction of pre-eclampsia. Br J Obstet Gynaecol. 1996, 103: 981-987.PubMedCrossRef Kyle PM, Campbell S, Buckley D, Kissane J, de Swiet M, Albano J, Millar JG, Redman CW: A comparison of the inactive urinary kallikrein:creatinine ratio and the angiotensin sensitivity test for the prediction of pre-eclampsia. Br J Obstet Gynaecol. 1996, 103: 981-987.PubMedCrossRef
54.
go back to reference Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC: Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999, 103: 945-952.PubMedCentralPubMedCrossRef Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC: Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999, 103: 945-952.PubMedCentralPubMedCrossRef
55.
go back to reference AbdAlla S, Lother H, el Massiery A, Quitterer U: Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med. 2001, 7: 1003-1009.PubMedCrossRef AbdAlla S, Lother H, el Massiery A, Quitterer U: Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med. 2001, 7: 1003-1009.PubMedCrossRef
56.
go back to reference Valdés G, Germain AM, Corthorn J, Berríos C, Foradori AC, Ferrario CM, Brosnihan KB: Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine. 2001, 16: 117-122.PubMedCrossRef Valdés G, Germain AM, Corthorn J, Berríos C, Foradori AC, Ferrario CM, Brosnihan KB: Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine. 2001, 16: 117-122.PubMedCrossRef
57.
go back to reference Merrill DC, Karoly M, Chen K, Ferrario CM, Brosnihan KB: Angiotensin-(1–7) in normal and preeclamptic pregnancy. Endocrine. 2002, 18: 239-245.PubMedCrossRef Merrill DC, Karoly M, Chen K, Ferrario CM, Brosnihan KB: Angiotensin-(1–7) in normal and preeclamptic pregnancy. Endocrine. 2002, 18: 239-245.PubMedCrossRef
58.
go back to reference Neves LA, Williams AF, Averill DB, Ferrario CM, Walkup MP, Brosnihan KB: Pregnancy enhances the angiotensin (Ang)-(1–7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1–7). Endocrinology. 2003, 144: 3338-3343.PubMedCrossRef Neves LA, Williams AF, Averill DB, Ferrario CM, Walkup MP, Brosnihan KB: Pregnancy enhances the angiotensin (Ang)-(1–7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1–7). Endocrinology. 2003, 144: 3338-3343.PubMedCrossRef
59.
go back to reference Evans PW, Wheeler T, Anthony FW, Osmond C: A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy. Hum Reprod. 1998, 13: 1057-1062.PubMedCrossRef Evans PW, Wheeler T, Anthony FW, Osmond C: A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy. Hum Reprod. 1998, 13: 1057-1062.PubMedCrossRef
60.
go back to reference Bosio PM, Wheeler T, Anthony F, Conroy R, O'Herlihy C, McKenna P: Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol. 2001, 184 (2): 146-152.PubMedCrossRef Bosio PM, Wheeler T, Anthony F, Conroy R, O'Herlihy C, McKenna P: Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol. 2001, 184 (2): 146-152.PubMedCrossRef
61.
go back to reference Brownbill P, McKeeman GC, Brockelsby JC, Crocker IP, Sibley CP: Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule. Endocrinology. 2007, 148: 4734-4744.PubMedCrossRef Brownbill P, McKeeman GC, Brockelsby JC, Crocker IP, Sibley CP: Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule. Endocrinology. 2007, 148: 4734-4744.PubMedCrossRef
62.
go back to reference Brockelsby JC, Anthony FW, Johnson IR, Baker PN: The effects of vascular endothelial growth factor on endothelial cells: a potential role in preeclampsia. Am J Obstet Gynecol. 2000, 182: 176-183.PubMedCrossRef Brockelsby JC, Anthony FW, Johnson IR, Baker PN: The effects of vascular endothelial growth factor on endothelial cells: a potential role in preeclampsia. Am J Obstet Gynecol. 2000, 182: 176-183.PubMedCrossRef
63.
go back to reference Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003, 111: 649-658.PubMedCentralPubMedCrossRef Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003, 111: 649-658.PubMedCentralPubMedCrossRef
64.
go back to reference Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA: Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol. 2006, 194: 1034-1041.PubMedCrossRef Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA: Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol. 2006, 194: 1034-1041.PubMedCrossRef
65.
go back to reference David AL, Torondel B, Zachary I, Wigley V, Abi-Nader K, Mehta V, Buckley SM, Cook T, Boyd M, Rodeck CH, Martin J, Peebles DM: Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Ther. 2008, 15 (19): 1344-1350.PubMedCrossRef David AL, Torondel B, Zachary I, Wigley V, Abi-Nader K, Mehta V, Buckley SM, Cook T, Boyd M, Rodeck CH, Martin J, Peebles DM: Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Ther. 2008, 15 (19): 1344-1350.PubMedCrossRef
66.
go back to reference Valdés G, Germain AM, Corthorn J, Berrios C, Foradori AC, Ferrario CM, Brosnihan KB: Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine. 2001, 16: 117-122.PubMedCrossRef Valdés G, Germain AM, Corthorn J, Berrios C, Foradori AC, Ferrario CM, Brosnihan KB: Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine. 2001, 16: 117-122.PubMedCrossRef
67.
go back to reference Salas SP, Marshall G, Gutierrez BL, Rosso P: Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension. 2006, 47: 203-208.PubMedCrossRef Salas SP, Marshall G, Gutierrez BL, Rosso P: Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension. 2006, 47: 203-208.PubMedCrossRef
68.
go back to reference Valdés G, Matthei R, Fernández MS, Schacht C, Corthorn J, Germain AM: Hipertensión pulmonar y embarazo. Rev Med Chil. 2002, 130: 201-208.PubMed Valdés G, Matthei R, Fernández MS, Schacht C, Corthorn J, Germain AM: Hipertensión pulmonar y embarazo. Rev Med Chil. 2002, 130: 201-208.PubMed
69.
go back to reference Hoos PC, Hoffman LH: Temporal aspects of rabbit uterine vascular and decidual responses to blastocyst stimulation. Biol Reprod. 1980, 23: 453-459.PubMedCrossRef Hoos PC, Hoffman LH: Temporal aspects of rabbit uterine vascular and decidual responses to blastocyst stimulation. Biol Reprod. 1980, 23: 453-459.PubMedCrossRef
70.
go back to reference Takemori K, Okamura H, Kanzaki H, Koshida M, Konishi I: Scanning electron microscopy study on corrosion cast of rat uterine vasculature during the first half of pregnancy. J Anat. 1984, 138: 163-173.PubMedCentralPubMed Takemori K, Okamura H, Kanzaki H, Koshida M, Konishi I: Scanning electron microscopy study on corrosion cast of rat uterine vasculature during the first half of pregnancy. J Anat. 1984, 138: 163-173.PubMedCentralPubMed
71.
go back to reference Psychoyos A: The decidual reaction is preceded by early changes in the capillary permeability of the uterus. C R Seances Soc Biol Fil. 1960, 154: 1384-1387.PubMed Psychoyos A: The decidual reaction is preceded by early changes in the capillary permeability of the uterus. C R Seances Soc Biol Fil. 1960, 154: 1384-1387.PubMed
72.
go back to reference Hoffman LH, Winfrey VP, Hoos PC: Sites of endometrial vascular leakage during implantation in the rabbit. Anat Rec. 1990, 227: 47-61.PubMedCrossRef Hoffman LH, Winfrey VP, Hoos PC: Sites of endometrial vascular leakage during implantation in the rabbit. Anat Rec. 1990, 227: 47-61.PubMedCrossRef
73.
go back to reference Benirschke K, Kaufmann P, Baergen RN: Early developmentof the human placenta. Pathology of the human placenta. Edited by: Benirschke K, Kaufmann P, Baergen RN. 2006, New York: Springer, 42-49. 5 Benirschke K, Kaufmann P, Baergen RN: Early developmentof the human placenta. Pathology of the human placenta. Edited by: Benirschke K, Kaufmann P, Baergen RN. 2006, New York: Springer, 42-49. 5
74.
go back to reference Craven CM, Morgan T, Ward K: Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta. 1998, 19: 241-252.PubMedCrossRef Craven CM, Morgan T, Ward K: Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta. 1998, 19: 241-252.PubMedCrossRef
75.
go back to reference Hees H, Moll W, Wrobel KH, Hees I: Pregnancy-induced structural changes and trophoblastic invasion in the segmental mesometrial arteries of the guinea-pig (cavia porcellus l.). Placenta. 1987, 8: 609-626.PubMedCrossRef Hees H, Moll W, Wrobel KH, Hees I: Pregnancy-induced structural changes and trophoblastic invasion in the segmental mesometrial arteries of the guinea-pig (cavia porcellus l.). Placenta. 1987, 8: 609-626.PubMedCrossRef
76.
go back to reference Beausejour A, Bibeau K, Lavoie JC, St-Louis J, Brochu M: Placental oxidative stress in a rat model of preeclampsia. Placenta. 2007, 28: 52-58.PubMedCrossRef Beausejour A, Bibeau K, Lavoie JC, St-Louis J, Brochu M: Placental oxidative stress in a rat model of preeclampsia. Placenta. 2007, 28: 52-58.PubMedCrossRef
77.
go back to reference Nanaev A, Chwalisz K, Frank HG, Kohnen G, Hegele-Hartung C, Kaufmann P: Physiological dilation of uteroplacental arteries in the guinea-pig depends on nitric oxide synthase activity of extravillous trophoblast. Cell Tissue Res. 1995, 282 (3): 407-421.PubMedCrossRef Nanaev A, Chwalisz K, Frank HG, Kohnen G, Hegele-Hartung C, Kaufmann P: Physiological dilation of uteroplacental arteries in the guinea-pig depends on nitric oxide synthase activity of extravillous trophoblast. Cell Tissue Res. 1995, 282 (3): 407-421.PubMedCrossRef
78.
go back to reference Corthorn J, Rey S, Chacón C, Valdés G: Spatio-temporal expression of MMP-2, MMP-9 and tissue kallikrein in uteroplacental units of the pregnant guinea-pig (cavia porcellus). Reprod Biol Endocrinol. 2007, 5: 27-PubMedCentralPubMedCrossRef Corthorn J, Rey S, Chacón C, Valdés G: Spatio-temporal expression of MMP-2, MMP-9 and tissue kallikrein in uteroplacental units of the pregnant guinea-pig (cavia porcellus). Reprod Biol Endocrinol. 2007, 5: 27-PubMedCentralPubMedCrossRef
79.
go back to reference Valdés G, Erices R, Chacon C, Corthorn J: Angiogenic, hyperpermeability and vasodilator network in utero-placental units along pregnancy in the guinea-pig (cavia porcellus). Reprod Biol Endocrinol. 2008, 6: 13-PubMedCentralPubMedCrossRef Valdés G, Erices R, Chacon C, Corthorn J: Angiogenic, hyperpermeability and vasodilator network in utero-placental units along pregnancy in the guinea-pig (cavia porcellus). Reprod Biol Endocrinol. 2008, 6: 13-PubMedCentralPubMedCrossRef
80.
go back to reference Elger W, Bartley J, Schneider B, Kaufmann G, Schubert G, Chwalisz K: Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity. Steroids. 2000, 65: 713-723.PubMedCrossRef Elger W, Bartley J, Schneider B, Kaufmann G, Schubert G, Chwalisz K: Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity. Steroids. 2000, 65: 713-723.PubMedCrossRef
81.
go back to reference Mess A, Zaki N, Kadyrov M, Korr H, Kaufmann P: Caviomorph placentation as a model for trophoblast invasion. Placenta. 2007, 28: 1234-1238.PubMedCrossRef Mess A, Zaki N, Kadyrov M, Korr H, Kaufmann P: Caviomorph placentation as a model for trophoblast invasion. Placenta. 2007, 28: 1234-1238.PubMedCrossRef
82.
go back to reference Frank HG, Kaufmann P: Nonvillous parts and trophoblast invasion. Pathology of the human placenta. Edited by: Benirschke K, Kaufmann P, Baergen RN. 2006, New York: Springer, 191-312. 5CrossRef Frank HG, Kaufmann P: Nonvillous parts and trophoblast invasion. Pathology of the human placenta. Edited by: Benirschke K, Kaufmann P, Baergen RN. 2006, New York: Springer, 191-312. 5CrossRef
83.
go back to reference Welsh T, Mitchell CM, Walters WA, Mesiano S, Zakar T: Prostaglandin H2 synthase-1 and -2 expression in guinea-pig gestational tissues during late pregnancy and parturition. J Physiol. 2005, 569: 903-912.PubMedCentralPubMedCrossRef Welsh T, Mitchell CM, Walters WA, Mesiano S, Zakar T: Prostaglandin H2 synthase-1 and -2 expression in guinea-pig gestational tissues during late pregnancy and parturition. J Physiol. 2005, 569: 903-912.PubMedCentralPubMedCrossRef
84.
go back to reference Kaufmann P, Davidoff M: The guinea-pig placenta. Adv Anat Embryol Cell Biol. 1977, 53: 5-91.PubMed Kaufmann P, Davidoff M: The guinea-pig placenta. Adv Anat Embryol Cell Biol. 1977, 53: 5-91.PubMed
85.
go back to reference Corthorn J, Figueroa C, Valdés G: Estrogen and luminal stimulation of rat uterine kallikrein. Biol Reprod. 1997, 56: 1432-1438.PubMedCrossRef Corthorn J, Figueroa C, Valdés G: Estrogen and luminal stimulation of rat uterine kallikrein. Biol Reprod. 1997, 56: 1432-1438.PubMedCrossRef
86.
go back to reference Corthorn J, Valdés G: Variations in uterine kallikrein during cycle and early pregnancy in the rat. Biol Reprod. 1994, 50: 1261-1264.PubMedCrossRef Corthorn J, Valdés G: Variations in uterine kallikrein during cycle and early pregnancy in the rat. Biol Reprod. 1994, 50: 1261-1264.PubMedCrossRef
87.
go back to reference Valdés G, Corthorn J, Scicli AG, Gaete V, Soto J, Ortíz ME, Foradori A, Saed GM: Uterine kallikrein in the early pregnant rat. Biol Reprod. 1993, 49: 802-808.PubMedCrossRef Valdés G, Corthorn J, Scicli AG, Gaete V, Soto J, Ortíz ME, Foradori A, Saed GM: Uterine kallikrein in the early pregnant rat. Biol Reprod. 1993, 49: 802-808.PubMedCrossRef
88.
go back to reference Figueroa CD, Chacón C, Corthorn J, Ehrenfeld P, Muller-Esterl W, Valdés G: Temporospatial changes of kinin B2 receptors during the estrous cycle and pregnancy in the rat uterus. Biol Reprod. 2001, 64: 1590-1599.PubMedCrossRef Figueroa CD, Chacón C, Corthorn J, Ehrenfeld P, Muller-Esterl W, Valdés G: Temporospatial changes of kinin B2 receptors during the estrous cycle and pregnancy in the rat uterus. Biol Reprod. 2001, 64: 1590-1599.PubMedCrossRef
89.
go back to reference Vercruysse L, Caluwaerts S, Luyten C, Pijnenborg R: Interstitial trophoblast invasion in the decidua and mesometrial triangle during the last third of pregnancy in the rat. Placenta. 2006, 27: 22-33.PubMedCrossRef Vercruysse L, Caluwaerts S, Luyten C, Pijnenborg R: Interstitial trophoblast invasion in the decidua and mesometrial triangle during the last third of pregnancy in the rat. Placenta. 2006, 27: 22-33.PubMedCrossRef
90.
go back to reference Neves LA, Stovall K, Joyner J, Valdés G, Gallagher PE, Ferrario CM, Merrill DC, Brosnihan KB: ACE2 and ANG-(1–7) in the rat uterus during early and late gestation. Am J Physiol Regul Integr Comp Physiol. 2008, 294: R151-161.PubMedCrossRef Neves LA, Stovall K, Joyner J, Valdés G, Gallagher PE, Ferrario CM, Merrill DC, Brosnihan KB: ACE2 and ANG-(1–7) in the rat uterus during early and late gestation. Am J Physiol Regul Integr Comp Physiol. 2008, 294: R151-161.PubMedCrossRef
91.
go back to reference Gilbert JS, Babcock SA, Granger JP: Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension. 2007, 50: 1142-1147.PubMedCrossRef Gilbert JS, Babcock SA, Granger JP: Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension. 2007, 50: 1142-1147.PubMedCrossRef
92.
go back to reference LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, Granger JP: Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension. 2008, 52: 1161-1167.PubMedCentralPubMedCrossRef LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, Granger JP: Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension. 2008, 52: 1161-1167.PubMedCentralPubMedCrossRef
93.
go back to reference LaMarca B, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP: Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension. 2008, 52: 1168-1172.PubMedCentralPubMedCrossRef LaMarca B, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP: Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension. 2008, 52: 1168-1172.PubMedCentralPubMedCrossRef
94.
go back to reference Zheng J, Wen Y, Chen DB, Bird IM, Magness RR: Angiotensin II elevates nitric oxide synthase 3 expression and nitric oxide production via a mitogen-activated protein kinase cascade in ovine fetoplacental artery endothelial cells. Biol Reprod. 2005, 72: 1421-1428.PubMedCrossRef Zheng J, Wen Y, Chen DB, Bird IM, Magness RR: Angiotensin II elevates nitric oxide synthase 3 expression and nitric oxide production via a mitogen-activated protein kinase cascade in ovine fetoplacental artery endothelial cells. Biol Reprod. 2005, 72: 1421-1428.PubMedCrossRef
95.
go back to reference Magness RR, Rosenfeld CR, Faucher DJ, Mitchell MD: Uterine prostaglandin production in ovine pregnancy: effects of angiotensin II and indomethacin. Am J Physiol. 1992, 263: H188-197.PubMed Magness RR, Rosenfeld CR, Faucher DJ, Mitchell MD: Uterine prostaglandin production in ovine pregnancy: effects of angiotensin II and indomethacin. Am J Physiol. 1992, 263: H188-197.PubMed
96.
go back to reference Zheng J, Bird IM, Chen DB, Magness RR: Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide. J Physiol. 2005, 565 (Pt 1): 59-69.PubMedCentralPubMedCrossRef Zheng J, Bird IM, Chen DB, Magness RR: Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide. J Physiol. 2005, 565 (Pt 1): 59-69.PubMedCentralPubMedCrossRef
97.
go back to reference Magness RR, Shaw CE, Phernetton TM, Zheng J, Bird IM: Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expression. Am J Physiol. 1997, 272: H1730-1740.PubMed Magness RR, Shaw CE, Phernetton TM, Zheng J, Bird IM: Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expression. Am J Physiol. 1997, 272: H1730-1740.PubMed
98.
go back to reference Broughton Pipkin F, Symonds EM, Turner SR: The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J Physiol. 1982, 323: 415-422.PubMedCentralPubMedCrossRef Broughton Pipkin F, Symonds EM, Turner SR: The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J Physiol. 1982, 323: 415-422.PubMedCentralPubMedCrossRef
99.
go back to reference Broughton Pipkin F, Wallace CP: The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus. Br J Pharmacol. 1986, 87: 533-542.PubMedCentralPubMedCrossRef Broughton Pipkin F, Wallace CP: The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus. Br J Pharmacol. 1986, 87: 533-542.PubMedCentralPubMedCrossRef
100.
go back to reference Forhead AJ, Fowden AL, Silver M, Hughes P, Broughton-Pipkin F, Sutherland MF: Haemodynamic responses to an angiotensin II receptor antagonist (GR 117289) in maternal and fetal sheep. Exp Physiol. 1995, 80: 285-298.PubMedCrossRef Forhead AJ, Fowden AL, Silver M, Hughes P, Broughton-Pipkin F, Sutherland MF: Haemodynamic responses to an angiotensin II receptor antagonist (GR 117289) in maternal and fetal sheep. Exp Physiol. 1995, 80: 285-298.PubMedCrossRef
101.
go back to reference Forhead AJ, Whybrew K, Hughes P, Broughton Pipkin F, Sutherland M, Fowden AL: Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation. Br J Pharmacol. 1996, 119: 393-401.PubMedCentralPubMedCrossRef Forhead AJ, Whybrew K, Hughes P, Broughton Pipkin F, Sutherland M, Fowden AL: Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation. Br J Pharmacol. 1996, 119: 393-401.PubMedCentralPubMedCrossRef
102.
go back to reference Ding ZQ, Rowe J, Ng B, Sinosich MJ, Gallery ED: Modulation of prostacyclin and thromboxane secretion by cytotrophoblasts from normal and pre-eclamptic human pregnancies. Placenta. 2002, 23: 594-599.PubMedCrossRef Ding ZQ, Rowe J, Ng B, Sinosich MJ, Gallery ED: Modulation of prostacyclin and thromboxane secretion by cytotrophoblasts from normal and pre-eclamptic human pregnancies. Placenta. 2002, 23: 594-599.PubMedCrossRef
103.
go back to reference Walsh SW: Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol. 1985, 152: 335-340.PubMedCrossRef Walsh SW: Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol. 1985, 152: 335-340.PubMedCrossRef
104.
go back to reference Robertson WB, Brosens I, Dixon G: Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens. 1976, 5: 115-127.PubMed Robertson WB, Brosens I, Dixon G: Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens. 1976, 5: 115-127.PubMed
105.
go back to reference Pijnenborg R, Bland JM, Robertson WB, Brosens I: Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta. 1983, 4: 397-413.PubMedCrossRef Pijnenborg R, Bland JM, Robertson WB, Brosens I: Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta. 1983, 4: 397-413.PubMedCrossRef
106.
go back to reference Lyall F, Bulmer JN, Kelly H, Duffie E, Robson SC: Human trophoblast invasion and spiral artery transformation: the role of nitric oxide. Am J Pathol. 1999, 154: 1105-1114.PubMedCentralPubMedCrossRef Lyall F, Bulmer JN, Kelly H, Duffie E, Robson SC: Human trophoblast invasion and spiral artery transformation: the role of nitric oxide. Am J Pathol. 1999, 154: 1105-1114.PubMedCentralPubMedCrossRef
107.
go back to reference Martin D, Conrad KP: Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta. Placenta. 2000, 21: 23-31.PubMedCrossRef Martin D, Conrad KP: Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta. Placenta. 2000, 21: 23-31.PubMedCrossRef
108.
go back to reference Al-Hijji J, Andolf E, Laurini R, Batra S: Nitric oxide synthase activity in human trophoblast, term placenta and pregnant myometrium. Reprod Biol Endocrinol. 2003, 1: 51-PubMedCentralPubMedCrossRef Al-Hijji J, Andolf E, Laurini R, Batra S: Nitric oxide synthase activity in human trophoblast, term placenta and pregnant myometrium. Reprod Biol Endocrinol. 2003, 1: 51-PubMedCentralPubMedCrossRef
109.
go back to reference González C, Cruz MA, Gallardo V, Lagos M, Varela J, Albornoz J, Schulz C: Nitric oxide and prostaglandin systems inhibition on the isolated perfused human placenta from normal and preeclamptic pregnancies. Gynecol Obstet Invest. 1995, 40: 244-248.PubMedCrossRef González C, Cruz MA, Gallardo V, Lagos M, Varela J, Albornoz J, Schulz C: Nitric oxide and prostaglandin systems inhibition on the isolated perfused human placenta from normal and preeclamptic pregnancies. Gynecol Obstet Invest. 1995, 40: 244-248.PubMedCrossRef
110.
go back to reference King RG, Gude NM, Di Iulio JL, Brennecke SP: Regulation of human placental fetal vessel tone: role of nitric oxide. Reprod Fertil Dev. 1995, 7: 1407-1411.PubMedCrossRef King RG, Gude NM, Di Iulio JL, Brennecke SP: Regulation of human placental fetal vessel tone: role of nitric oxide. Reprod Fertil Dev. 1995, 7: 1407-1411.PubMedCrossRef
111.
go back to reference Chaudhuri G, Cuevas J, Buga GM, Ignarro LJ: NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels. Am J Physiol. 1993, 265: H2036-2043.PubMed Chaudhuri G, Cuevas J, Buga GM, Ignarro LJ: NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels. Am J Physiol. 1993, 265: H2036-2043.PubMed
112.
go back to reference Germain AM, Valdés G, Romanik MC, Reyes MS: Evidence supporting a beneficial role for long-term l-arginine supplementation in high-risk pregnancies. Hypertension. 2004, 44: e1-PubMedCrossRef Germain AM, Valdés G, Romanik MC, Reyes MS: Evidence supporting a beneficial role for long-term l-arginine supplementation in high-risk pregnancies. Hypertension. 2004, 44: e1-PubMedCrossRef
113.
go back to reference Neri I, Mazza V, Galassi MC, Volpe A, Facchinetti F: Effects of l-arginine on utero-placental circulation in growth-retarded fetuses. Acta Obstet Gynecol Scand. 1996, 75: 208-212.PubMedCrossRef Neri I, Mazza V, Galassi MC, Volpe A, Facchinetti F: Effects of l-arginine on utero-placental circulation in growth-retarded fetuses. Acta Obstet Gynecol Scand. 1996, 75: 208-212.PubMedCrossRef
114.
go back to reference Neri I, Jasonni VM, Gori GF, Blasi I, Facchinetti F: Effect of l-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial. J Matern Fetal Neonatal Med. 2006, 19: 277-281.PubMedCrossRef Neri I, Jasonni VM, Gori GF, Blasi I, Facchinetti F: Effect of l-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial. J Matern Fetal Neonatal Med. 2006, 19: 277-281.PubMedCrossRef
115.
go back to reference Rytlewski K, Olszanecki R, Korbut R, Zdebski Z: Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest. 2005, 35: 32-37.PubMedCrossRef Rytlewski K, Olszanecki R, Korbut R, Zdebski Z: Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest. 2005, 35: 32-37.PubMedCrossRef
116.
go back to reference Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F: Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension. 1996, 28: 488-493.PubMedCrossRef Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F: Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension. 1996, 28: 488-493.PubMedCrossRef
117.
go back to reference Shaamash AH, Elsonosy ED, Zakhari MM, Radwan SH, El-Dien HM: Placental nitric oxide synthase (NOS) activity and nitric oxide (NO) production in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet. 2001, 72: 127-133.PubMedCrossRef Shaamash AH, Elsonosy ED, Zakhari MM, Radwan SH, El-Dien HM: Placental nitric oxide synthase (NOS) activity and nitric oxide (NO) production in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet. 2001, 72: 127-133.PubMedCrossRef
118.
go back to reference Norris LA, Higgins JR, Darling MR, Walshe JJ, Bonnar J: Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia. Obstet Gynecol. 1999, 93 (6): 958-963.PubMedCrossRef Norris LA, Higgins JR, Darling MR, Walshe JJ, Bonnar J: Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia. Obstet Gynecol. 1999, 93 (6): 958-963.PubMedCrossRef
119.
go back to reference Schiessl B, Mylonas I, Hantschmann P, Kuhn C, Schulze S, Kunze S, Friese K, Jeschke U: Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, preeclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem. 2005, 53: 1441-1449.PubMedCentralPubMedCrossRef Schiessl B, Mylonas I, Hantschmann P, Kuhn C, Schulze S, Kunze S, Friese K, Jeschke U: Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, preeclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem. 2005, 53: 1441-1449.PubMedCentralPubMedCrossRef
120.
go back to reference Corthorn J, Germain AA, Chacón C, Rey S, Soto GX, Figueroa CD, Muller-Esterl W, Duarte I, Valdés G: Expression of kallikrein, bradykinin B2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta. Endocrine. 2006, 29: 491-499.PubMedCrossRef Corthorn J, Germain AA, Chacón C, Rey S, Soto GX, Figueroa CD, Muller-Esterl W, Duarte I, Valdés G: Expression of kallikrein, bradykinin B2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta. Endocrine. 2006, 29: 491-499.PubMedCrossRef
121.
go back to reference Orange SJ, Painter D, Horvath J, Yu B, Trent R, Hennessy A: Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia. Clin Exp Pharmacol Physiol. 2003, 30: 376-381.PubMedCrossRef Orange SJ, Painter D, Horvath J, Yu B, Trent R, Hennessy A: Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia. Clin Exp Pharmacol Physiol. 2003, 30: 376-381.PubMedCrossRef
122.
go back to reference Wang Y, Walsh SW, Parnell R, Han H: Placental production of nitric oxide and endothelin in normal and preeclamptic pregnancies. Hypertension Pregnancy. 1994, 13: 171-178.CrossRef Wang Y, Walsh SW, Parnell R, Han H: Placental production of nitric oxide and endothelin in normal and preeclamptic pregnancies. Hypertension Pregnancy. 1994, 13: 171-178.CrossRef
123.
go back to reference Conrad KP, Davis AK: Nitric oxide synthase activity in placentae from women with pre-eclampsia. Placenta. 1995, 16: 691-699.PubMedCrossRef Conrad KP, Davis AK: Nitric oxide synthase activity in placentae from women with pre-eclampsia. Placenta. 1995, 16: 691-699.PubMedCrossRef
124.
go back to reference Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, Macconi D, Maucci R, Porrati F, Benigni A, Picciolo C, Remuzzi G: L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension. 2004, 43: 614-622.PubMedCrossRef Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, Macconi D, Maucci R, Porrati F, Benigni A, Picciolo C, Remuzzi G: L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension. 2004, 43: 614-622.PubMedCrossRef
125.
go back to reference Amarnani S, Sangrat B, Chaudhuri G: Effects of selected endothelium-dependent vasodilators on fetoplacental vasculature: physiological implications. Am J Physiol. 1999, 277: H842-847.PubMed Amarnani S, Sangrat B, Chaudhuri G: Effects of selected endothelium-dependent vasodilators on fetoplacental vasculature: physiological implications. Am J Physiol. 1999, 277: H842-847.PubMed
126.
go back to reference Acker GM, Galen FX, Devaux C, Foote S, Papernik E, Pesty A, Menard J, Corvol P: Human chorionic cells in primary culture: a model for renin biosynthesis. J Clin Endocrinol Metab. 1982, 55: 902-909.PubMedCrossRef Acker GM, Galen FX, Devaux C, Foote S, Papernik E, Pesty A, Menard J, Corvol P: Human chorionic cells in primary culture: a model for renin biosynthesis. J Clin Endocrinol Metab. 1982, 55: 902-909.PubMedCrossRef
127.
go back to reference Hodari AA, Smeby R, Bumpus FM: A renin-like substance in the human placenta. Obstet Gynecol. 1967, 29: 313-317.PubMed Hodari AA, Smeby R, Bumpus FM: A renin-like substance in the human placenta. Obstet Gynecol. 1967, 29: 313-317.PubMed
128.
go back to reference Symonds EM, Stanley MA, Skinner SL: Production of renin by in vitro cultures of human chorion and uterine muscle. Nature. 1968, 217: 1152-1153.PubMedCrossRef Symonds EM, Stanley MA, Skinner SL: Production of renin by in vitro cultures of human chorion and uterine muscle. Nature. 1968, 217: 1152-1153.PubMedCrossRef
129.
go back to reference Kreft-Jais C, Plouin PF, Tchobroutsky C, Boutroy MJ: Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril. Br J Obstet Gynaecol. 1988, 95: 420-422.PubMedCrossRef Kreft-Jais C, Plouin PF, Tchobroutsky C, Boutroy MJ: Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril. Br J Obstet Gynaecol. 1988, 95: 420-422.PubMedCrossRef
130.
go back to reference Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA: Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 1991, 78: 128-135.PubMed Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA: Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 1991, 78: 128-135.PubMed
131.
go back to reference Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP, Lalouel JM: A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 1993, 4 (1): 59-61.PubMedCrossRef Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP, Lalouel JM: A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 1993, 4 (1): 59-61.PubMedCrossRef
132.
go back to reference Inoue I, Rohrwasser A, Helin C, Jeunemaitre X, Crain P, Bohlender J, Lifton RP, Corvol P, Ward K, Lalouel JM: A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem. 1995, 270: 11430-11436.PubMedCrossRef Inoue I, Rohrwasser A, Helin C, Jeunemaitre X, Crain P, Bohlender J, Lifton RP, Corvol P, Ward K, Lalouel JM: A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem. 1995, 270: 11430-11436.PubMedCrossRef
133.
go back to reference Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A: Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996, 274: 995-998.PubMedCrossRef Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A: Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996, 274: 995-998.PubMedCrossRef
134.
go back to reference Corthorn J, Germain AA, Chacon C, Rey S, Soto GX, Figueroa CD, Muller-Esterl W, Duarte I, Valdes G: Expression of kallikrein, bradykinin B2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta. Endocrine. 2006, 29: 491-499.PubMedCrossRef Corthorn J, Germain AA, Chacon C, Rey S, Soto GX, Figueroa CD, Muller-Esterl W, Duarte I, Valdes G: Expression of kallikrein, bradykinin B2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta. Endocrine. 2006, 29: 491-499.PubMedCrossRef
135.
go back to reference Anton L, Merrill DC, Neves LA, Stovall K, Gallagher PE, Diz DI, Moorefield C, Gruver C, Ferrario CM, Brosnihan KB: Activation of local chorionic villi angiotensin II levels but not angiotensin (1–7) in preeclampsia. Hypertension. 2008, 51: 1066-1072.PubMedCentralPubMedCrossRef Anton L, Merrill DC, Neves LA, Stovall K, Gallagher PE, Diz DI, Moorefield C, Gruver C, Ferrario CM, Brosnihan KB: Activation of local chorionic villi angiotensin II levels but not angiotensin (1–7) in preeclampsia. Hypertension. 2008, 51: 1066-1072.PubMedCentralPubMedCrossRef
136.
go back to reference Anton L, Merrill DC, Neves LAA, Diz DI, Corthorn J, Valdes G, Stovall K, Gallagher PE, Moorefield C, Gruver C, Brosnihan KB: The uterine placental bed renin-angiotensin system in normal and preeclamptic pregnancy [Epub ahead of print]. Endocrinology. 2009 Anton L, Merrill DC, Neves LAA, Diz DI, Corthorn J, Valdes G, Stovall K, Gallagher PE, Moorefield C, Gruver C, Brosnihan KB: The uterine placental bed renin-angiotensin system in normal and preeclamptic pregnancy [Epub ahead of print]. Endocrinology. 2009
137.
go back to reference Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Qadri F, Hering L, Muller DN, Luft FC, Staff AC: Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension. 2007, 49: 604-611.PubMedCrossRef Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Qadri F, Hering L, Muller DN, Luft FC, Staff AC: Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension. 2007, 49: 604-611.PubMedCrossRef
138.
go back to reference Krussel JS, Casan EM, Raga F, Hirchenhain J, Wen Y, Huang HY, Bielfeld P, Polan ML: Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt in cycling human endometrium. Mol Hum Reprod. 1999, 5: 452-458.PubMedCrossRef Krussel JS, Casan EM, Raga F, Hirchenhain J, Wen Y, Huang HY, Bielfeld P, Polan ML: Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt in cycling human endometrium. Mol Hum Reprod. 1999, 5: 452-458.PubMedCrossRef
139.
go back to reference Moller B, Lindblom B, Olovsson M: Expression of the vascular endothelial growth factors B and C and their receptors in human endometrium during the menstrual cycle. Acta Obstet Gynecol Scand. 2002, 81: 817-824.PubMedCrossRef Moller B, Lindblom B, Olovsson M: Expression of the vascular endothelial growth factors B and C and their receptors in human endometrium during the menstrual cycle. Acta Obstet Gynecol Scand. 2002, 81: 817-824.PubMedCrossRef
140.
go back to reference Krussel JS, Behr B, Milki AA, Hirchenhain J, Wen Y, Bielfeld P, Lake Polan M: Vascular endothelial growth factor (VEGF) mRNA splice variants are differentially expressed in human blastocysts. Mol Hum Reprod. 2001, 7: 57-63.PubMedCrossRef Krussel JS, Behr B, Milki AA, Hirchenhain J, Wen Y, Bielfeld P, Lake Polan M: Vascular endothelial growth factor (VEGF) mRNA splice variants are differentially expressed in human blastocysts. Mol Hum Reprod. 2001, 7: 57-63.PubMedCrossRef
141.
go back to reference Demir R, Kayisli UA, Seval Y, Celik-Ozenci C, Korgun ET, Demir-Weusten AY, Huppertz B: Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta. 2004, 25: 560-572.PubMedCrossRef Demir R, Kayisli UA, Seval Y, Celik-Ozenci C, Korgun ET, Demir-Weusten AY, Huppertz B: Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta. 2004, 25: 560-572.PubMedCrossRef
142.
go back to reference Jackson MR, Carney EW, Lye SJ, Ritchie JW: Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta. 1994, 15: 341-353.PubMedCrossRef Jackson MR, Carney EW, Lye SJ, Ritchie JW: Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta. 1994, 15: 341-353.PubMedCrossRef
143.
go back to reference Shiraishi S, Nakagawa K, Kinukawa N, Nakano H, Sueishi K: Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta. 1996, 17: 111-121.PubMedCrossRef Shiraishi S, Nakagawa K, Kinukawa N, Nakano H, Sueishi K: Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta. 1996, 17: 111-121.PubMedCrossRef
144.
go back to reference Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ: Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest. 1993, 91: 950-960.PubMedCentralPubMedCrossRef Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ: Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest. 1993, 91: 950-960.PubMedCentralPubMedCrossRef
145.
go back to reference Schiessl B, Innes BA, Bulmer JN, Otun HA, Chadwick TJ, Robson SC, Lash GE: Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta. 2009, 30: 79-87.PubMedCrossRef Schiessl B, Innes BA, Bulmer JN, Otun HA, Chadwick TJ, Robson SC, Lash GE: Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta. 2009, 30: 79-87.PubMedCrossRef
146.
go back to reference Wallenburg HCS: Hemodynamics in hypertensive pregnancy. Hypertension in pregnancy. Edited by: Rubin P. 2000, Amsterdam: Elsevier, 181-220. 2 Wallenburg HCS: Hemodynamics in hypertensive pregnancy. Hypertension in pregnancy. Edited by: Rubin P. 2000, Amsterdam: Elsevier, 181-220. 2
147.
go back to reference Wallenburg HCS: Prevention of hypertensive disorders in pregnancy. Clin Exp Hypertens Pregnancy. 1988, 7: 121-137.CrossRef Wallenburg HCS: Prevention of hypertensive disorders in pregnancy. Clin Exp Hypertens Pregnancy. 1988, 7: 121-137.CrossRef
148.
go back to reference Wallenburg HCS, Bremer HA: Principles and applications of manipulation of prostaglandin synthesis in pregnancy. Clin Obstet Gynaecol. 1992, 6: 859-891. Wallenburg HCS, Bremer HA: Principles and applications of manipulation of prostaglandin synthesis in pregnancy. Clin Obstet Gynaecol. 1992, 6: 859-891.
Metadata
Title
Vasodilator factors in the systemic and local adaptations to pregnancy
Authors
Gloria Valdes
Peter Kaufmann
Jenny Corthorn
Rafaela Erices
K Bridget Brosnihan
JaNae Joyner-Grantham
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2009
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-7-79

Other articles of this Issue 1/2009

Reproductive Biology and Endocrinology 1/2009 Go to the issue